Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Nephrology · BK Virus Nephropathy

Life After BK: Long-Term Monitoring and Health

At a Glance

After BK virus nephropathy is no longer detected in blood, ongoing transplant follow-up remains important because kidney scarring may leave lower kidney function or higher creatinine, and a later rise may signal recurrent virus, rejection, medication toxicity, or another complication.

When your blood tests finally report that the BK virus is “not detected,” it is a significant victory. However, for many patients, the transition into “survivorship” means moving from active treatment to long-term vigilance. The virus and the treatment used to fight it can leave lasting marks on your kidney’s health [1][2].

The Reality of Viral Clearance

A test result showing the virus is “not detected in plasma” means the amount of viral DNA in your blood has fallen below the assay’s detection limit at that specific time. It does not necessarily prove that the virus has been completely eradicated; low-level tissue or urine infection can persist, and recurrence is possible [3].

Furthermore, clearing the virus from the blood does not mean the kidney is completely unharmed. The inflammation and injury caused by the virus can lead to interstitial fibrosis (scarring) and tubular atrophy (thinning of the kidney’s filtering tubes) [4]. Because of this, you may find that your eGFR (estimated glomerular filtration rate) is lower, or your creatinine is higher, than it was before the infection started [5].

While a stable, slightly lower baseline kidney function can occur, this “new normal” is only established after your transplant team confirms your kidney is stable. Any subsequent rise in your creatinine must still be thoroughly evaluated, as it could signal a recurrence of the virus, organ rejection, drug toxicity, or another complication [2].

Long-Term Monitoring: Staying Vigilant

While the most intense period of risk for the BK virus is within the first two years after your transplant, long-term monitoring remains essential [1][6]:

  • The First 2 Years: Typically, blood tests are monthly for 9 months, then every 3 months through the end of the second year [1].
  • Beyond 2 Years: Routine monthly screening often stops, but your long-term schedule is individualized. “Late-onset” BKV has been reported years after a transplant, though it is uncommon [7][8].

Your doctor will likely order a “spot check” of your BK viral load if you experience a sudden rise in creatinine or if you require a major increase in your immunosuppression, such as needing high-dose steroids for another condition [7][8].

Life After BKVN

The long-term outlook for your kidney depends heavily on how early the virus was caught, how severe the infection was, and whether any permanent scarring occurred. Patients whose infections are caught early and cleared quickly often have a better outlook than those who suffer persistent infections or significant fibrosis (such as Banff Class 3) [2][9].

The most important thing you can do during this phase is to attend every follow-up appointment and stay consistent with your adjusted medication schedule. If you find yourself struggling with the anxiety of graft loss, ask your team about speaking with a transplant social worker or counselor. Keeping your immune system in balance is the key to a long-lasting transplant, and you and your team will navigate that path together [10].

Common questions in this guide

Does an undetectable BK virus blood test mean the infection is gone?
Not necessarily. “Not detected” means the amount of BK virus genetic material in the blood was below the test’s detection limit at that time; small amounts may remain in urine or kidney tissue, and the virus can return. Continued follow-up is therefore important.
How often are BK virus tests needed after a kidney transplant?
Testing is often done monthly for the first 9 months after transplant and every 3 months through the end of year 2. After 2 years, routine monthly testing may stop, but your transplant team may order a test if creatinine rises or immunosuppressive treatment is increased.
Can BK virus nephropathy leave permanent kidney damage?
Yes. Inflammation from the infection can cause scarring and thinning of the kidney’s filtering tubes, which may leave you with a lower estimated kidney-filtering rate, or eGFR, and higher creatinine than before. Your team must confirm that these values are stable before treating them as your new baseline.
What does a later rise in creatinine mean after BK virus nephropathy?
A rise can have several causes, including recurrent BK virus, rejection of the transplanted kidney, medication toxicity, or another complication. It should be reviewed by your transplant team rather than assumed to be your usual fluctuation.
What does the ci score on a transplant biopsy tell me?
The ci score describes the amount of scarring in the tissue between the kidney’s filtering structures on a biopsy. A higher score generally indicates more permanent scarring, so ask your transplant team how your result affects kidney function and long-term outlook.
Can BK virus nephropathy recur years after a transplant?
It can, although late-onset BK virus nephropathy years after transplant is uncommon. Your team may check the BK viral load, or amount of virus in the blood, if kidney function worsens or if you need a major increase in immunosuppressive medicine, such as high-dose steroids.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Now that the virus is not detected in my blood, how often will we continue to check my BK viral load?
  2. 2.How does my current eGFR (kidney function) compare to my baseline before the BK infection began?
  3. 3.What is my current 'ci' score from my last biopsy, and how does that affect my kidney's long-term health?
  4. 4.Are there any specific 'warning signs' or changes in my labs that should trigger a return to monthly monitoring?
  5. 5.If I need to undergo chemotherapy or take steroids for another condition in the future, how will we adjust my BK monitoring?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (10)
  1. 1

    The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation.

    Kotton CN, Kamar N, Wojciechowski D, et al.

    Transplantation 2024; (108(9)):1834-1866 doi:10.1097/TP.0000000000004976.

    PMID: 38605438
  2. 2

    Incidence, risk factors, and outcome of BK polyomavirus infection after kidney transplantation.

    Favi E, Puliatti C, Sivaprakasam R, et al.

    World journal of clinical cases 2019; (7(3)):270-290 doi:10.12998/wjcc.v7.i3.270.

    PMID: 30746369
  3. 3

    Efficacy of mTOR Inhibitors and Intravenous Immunoglobulin for Treatment of Polyoma BK Nephropathy in Kidney Transplant Recipients: A Biopsy-Proven Study.

    Karatas M, Tatar E, Okut G, et al.

    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2024; (22(Suppl 1)):118-127 doi:10.6002/ect.MESOT2023.O29.

    PMID: 38385385
  4. 4

    T-cell adoptive immunotherapy for BK nephropathy in renal transplantation.

    Jahan S, Scuderi C, Francis L, et al.

    Transplant infectious disease : an official journal of the Transplantation Society 2020; (22(6)):e13399 doi:10.1111/tid.13399.

    PMID: 32608543
  5. 5

    The Prevalence and Outcomes of BK Polyoma Virus Nephropathy in Living Donor Kidney Transplant Recipients.

    Rana A, Bansal SB, Kotton CN, et al.

    Indian journal of nephrology 2025; (35(3)):343-348 doi:10.25259/ijn_87_23.

    PMID: 40352877
  6. 6

    BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.

    Hirsch HH, Randhawa PS,

    Clinical transplantation 2019; (33(9)):e13528 doi:10.1111/ctr.13528.

    PMID: 30859620
  7. 7

    Case Report: Late-onset BK polyomavirus-associated nephropathy in kidney transplant recipients: two cases and insights into underlying mechanisms.

    Belčič Mikič T, Bošnjak M, Arnol M

    Frontiers in medicine 2026; (13()):1799421 doi:10.3389/fmed.2026.1799421.

    PMID: 42519800
  8. 8

    Late BK Nephropathy 15 years post kidney transplant following chemotherapy: A case report.

    Hamiduzzaman A, Hou J, Higgins T, et al.

    IDCases 2025; (41()):e02340 doi:10.1016/j.idcr.2025.e02340.

    PMID: 40837613
  9. 9

    Importance of Follow-Up Biopsies in the Prediction of Renal Allograft Survival Following Polyomavirus-Associated Nephropathy.

    Özdemir BH, Ok Atılgan A, Akyüz Özdemir A, et al.

    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2023; (21(7)):568-577 doi:10.6002/ect.2023.0080.

    PMID: 37584537
  10. 10

    BK Virus in Kidney Transplant: Current Concepts, Recent Advances, and Future Directions.

    Sharma R, Tzetzo S, Patel S, et al.

    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2016; (14(4)):377-84 doi:10.6002/ect.2016.0030.

    PMID: 27267780

This page is for informational purposes only and does not constitute medical advice. Your transplant team should interpret your BK viral load, creatinine, eGFR, and biopsy results and set your individualized follow-up plan.

Get notified when new evidence is published on BK-virus nephropathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.